Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)
Condition(s):Hepatitis C, Chronic; Liver CirrhosisLast Updated:March 13, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Hepatitis C, Chronic; Liver CirrhosisLast Updated:March 13, 2017Terminated
Condition(s):Chronic Hepatitis C Virus InfectionLast Updated:September 22, 2005Completed
Condition(s):Localized Osteosarcoma; Metastatic OsteosarcomaLast Updated:June 7, 2023Completed
Condition(s):Chronic Hepatitis CLast Updated:July 12, 2017Withdrawn
Condition(s):Hepatitis C, ChronicLast Updated:January 14, 2016Completed
Condition(s):Renal Cell Carcinoma; MelanomaLast Updated:September 13, 2022Completed
Condition(s):Hepatitis BLast Updated:April 13, 2021Completed
Condition(s):Hepatitis C, Chronic; Insulin ResistanceLast Updated:April 7, 2017Terminated
Condition(s):Hepatitis C, ChronicLast Updated:November 18, 2019Completed
Condition(s):Chronic Hepatitis CLast Updated:July 27, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.